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OBJECTIVES We sought to assess the relationship between the Thrombolysis In Myocardial Infarction
(TIMI) myocardial perfusion (TMP) grade and myocardial salvage as well as the usefulness
of TMP grade in comparing two different reperfusion strategies.
BACKGROUND The angiographic index of TMP grade correlates with infarct size and mortality after
thrombolysis for acute myocardial infarction (AMI). Its relationship to myocardial salvage
and its usefulness in comparing different reperfusion strategies are not known.
METHODS We analyzed the TMP grade on angiograms obtained at one to two weeks after treatment in
267 patients enrolled in two randomized trials that compared stenting with thrombolysis in
AMI. Patients were classified into two groups: 159 patients with TMP grade 2/3 and 108
patients with TMP grade 0/1. Two scintigraphic studies were performed: before and one to
two weeks after reperfusion. The salvage index was calculated as the proportion of the area at
risk salvaged by reperfusion.
RESULTS Patients with TMP grade 2/3 had a higher salvage index (0.49  0.42 vs. 0.34  0.49, p 
0.01), a smaller final infarct size (15.4  15.5% vs. 22.1  16.2% of the left ventricle, p 
0.001), and a trend toward lower one-year mortality (3.8% vs. 8.3%, p  0.11) than patients
with TMP grade 0/1. The relationship between TMP and salvage index was independent of
the form of reperfusion therapy. The proportion of patients with TMP grade 2/3 was
significantly higher after stenting than after thrombolysis (70.9% vs. 48.1%, p  0.001).
CONCLUSIONS These findings show that the TMP grade is a useful marker of the degree of myocardial
salvage achieved with reperfusion and a sensitive indicator of the efficacy of reperfusion
strategies in patients with AMI. (J Am Coll Cardiol 2003;41:925–9) © 2003 by the
American College of Cardiology Foundation
The current concept of optimal reperfusion in acute myo-
cardial infarction (AMI) includes not only the rapid and
sustained restoration of blood flow in the epicardial artery,
but also the restoration of perfusion at the tissue level within
the jeopardized myocardium (1). The failure to achieve an
adequate blood supply at this level has been associated with
a greater infarct size, poor left ventricular (LV) function and
remodeling, congestive heart failure, and higher mortality,
despite the presence of a patent infarct-related artery (IRA)
(2,3). The cause of the no-reflow phenomenon has been
attributed to microvascular dysfunction (4), which is a
complex phenomenon that initiates with the onset of
ischemia and extends up to 48 h afterward.
Several diagnostic techniques have been employed to
evaluate tissue-level microvascular perfusion in the last
decade. Studies using myocardial contrast echocardiogra-
phy, magnetic resonance, Doppler flow wire, nuclear imag-
ing, ST-segment resolution, myocardial blush, and cor-
rected Thrombolysis In Myocardial Infarction (TIMI)
frame count have provided investigators with information
on the incidence of no-reflow and its clinical consequences
in patients with abnormal perfusion at tissue-level myocar-
dium (2,5–10). Recently, Gibson et al. (11) introduced a
new angiographic index—TIMI myocardial perfusion
(TMP) grade—as a predictor of mortality in patients with
AMI. Although the TMP grade correlates with the final
infarct size in patients with AMI treated with thrombolysis
(12), it is still unclear whether this index also reflects the
degree of myocardial salvage produced by various reperfu-
sion strategies. The aim of our study was to assess whether
the TMP grade may serve as an angiographic marker of
myocardial salvage achieved with stenting or thrombolysis
in patients with AMI and, consequently, as an indicator of
reperfusion efficacy.
METHODS
The Stent versus Thrombolysis for Occluded coronary
arteries in Patients with Acute Myocardial Infarction
(STOPAMI)-1 and -2 were two randomized trials that
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compared stenting with thrombolysis in 302 patients with
AMI within the first 12 h from symptom onset (13,14).
Details of the inclusion criteria and reperfusion regimen
have been published previously (13,14). In brief, stenting
was always combined with abciximab, and thrombolysis
consisted of either full-dose alteplase alone (STOPAMI-1)
or half-dose alteplase plus abciximab (STOPAMI-2)
(13,14). A six-month visit to the outpatient clinic and
12-month phone contact were carried out for all patients.
The protocol of both randomized studies was approved by
the local Ethics Committee, and patients gave written,
informed consent for participation.
Angiographic evaluation. A coronary angiogram was
scheduled to be performed one to two weeks after random-
ization in all patients. Of the 290 patients who survived to
this time point, 23 did not consent to planned angiography.
Therefore, the angiograms of 267 patients were available for
assessment of TMP grade. Of these patients, 134 had been
randomized to stenting and 133 to thrombolysis (62 pa-
tients without and 71 patients with abciximab). The assess-
ment was done in the Angiographic Core Laboratory by
investigators who were unaware of the scintigraphic results
or clinical outcome. We applied the grading system de-
scribed by Gibson et al. (11). Briefly, in TMP grade 0, dye
fails to enter the microvasculature; in TMP grade 1, dye
enters but fails to exit the microvasculature (persisting on
the subsequent injection); in TMP grade 2, dye enters and
slowly exits the microvasculature (staining is not present on
the subsequent injection); and in TMP grade 3, there is
normal entry and mild persistence of dye at the end of the
injection. Grades 0 and 1 of TMP were considered to
indicate closed myocardium, whereas TMP grades 2 and 3
were considered to indicate open myocardium, with respect
to microvascular integrity and perfusion at the myocardial
tissue level (12). Assessment of TMP was done during
contrast injection of either the IRA or the vessel supplying
collateral channels to the IRA, in case the latter was
occluded. The angiographic projections used for the evalu-
ation of TMP grade were those that allowed for optimal
visualization of the myocardial territory supplied by the
IRA, without superimposition of myocardial regions sup-
plied by non-IRAs. Anterograde flow in the IRA was
assessed according to the TIMI grading system (15).
Scintigraphic evaluation. All patients received an intrave-
nous injection of 27 mCi (1,000 MBq) of technetium-99m
sestamibi immediately after randomization. Single-photon
emission computed tomography was performed within 6 to
8 h of injection of the radionuclide to calculate the initial
perfusion defect representing the area at risk. A second
scintigraphic study was performed 7 to 14 days after primary
treatment for calculation of the final infarct size. The
salvage index was calculated as the proportion of the initial
area at risk salvaged by reperfusion. Paired scintigraphic
studies necessary for calculation of the salvage index were
available in 248 (93%) of the 267 patients included in this
study.
Statistical analysis. Data are presented as the mean value
 SD, counts, or percentages. The analysis consisted of a
comparison between patients with TMP grade 0 or 1
(closed myocardium) and those with TMP grade 2 or 3
(open myocardium). An additional comparison was made
between the two reperfusion strategies—stenting and
thrombolysis. Differences between the groups, with respect
to continuous variables, were compared by the two-sided t
test. The two-sided chi-squared or Fisher exact test (when-
ever an expected cell value was 5) was used for analysis of
categorical variables. The relationship between TMP grade
and myocardial salvage (continuous response variable) was
adjusted for other co-variates, including the reperfusion
therapy option, in a multivariate model based on multiple
linear regression analysis. A p value 0.05 was considered
statistically significant.
RESULTS
Grade 2/3 TMP was found in 159 patients (62 patients with
grade 2 and 97 patients with grade 3) and grade 0/1 TMP
in 108 patients (58 patients with grade 0 and 50 patients
with grade 1). Table 1 shows that there were no significant
differences between the two groups with respect to the
baseline characteristics, except for the proportion of smok-
ers, which was higher in the group with TMP grade 2/3.
TIMI flow grade 3 (complete epicardial flow restoration)
was present in 90.6% of the patients with TMP grade 2/3
and in 41.7% of those with TMP grade 0/1 (p  0.001).
TMP grade as an indicator of myocardial salvage and
clinical outcome. Although there were no differences in
the initial perfusion defect (Table 1) between the two
groups, patients with TMP grade 2/3 had a significantly
higher salvage index (0.49  0.42 vs. 0.34  0.49, p 
0.01), a smaller final infarct size (15.4  15.5% vs. 22.1 
16.2% of the LV, p  0.001), and a trend toward lower
one-year mortality (3.8% vs. 8.3%, p  0.11) than patients
with TMP grade 0/1 (Fig. 1). In addition, the angiographic
ejection fraction of the LV, available in 261 of the 267 study
patients, was significantly higher among patients with TMP
grade 2/3 (58.3  12.7% vs. 53.1  12.3% in patients with
TMP grade 0/1, p  0.001). After adjustment for other
co-variates (factors shown in Table 1 plus TIMI flow
Abbreviations and Acronyms
AMI  acute myocardial infarction
IRA  infarct-related artery
LV  left ventricle, left ventricular
STOPAMI  Stent versus Thrombolysis for Occluded
coronary arteries in Patients with Acute
Myocardial Infarction trial
TIMI  Thrombolysis In Myocardial Infarction
TMP  TIMI myocardial perfusion
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grade), a higher TMP grade was independently correlated
with a higher salvage index (p  0.001). The TMP grade
ranked second, immediately after the type of reperfusion
therapy (F value  11, p  0.001), as an independent
predictor of myocardial salvage. In this model, the conven-
tional TIMI flow grades showed a much weaker correlation
with myocardial salvage (p  0.048). In a second step, we
forced the angiographic ejection fraction of the LV into the
same multivariate model to assess whether the TMP grade
maintains its independent predictive value for myocardial
salvage after this adjustment. On the basis of the results
yielded by this new model, the TMP grade continued to be
a significant independent predictor of myocardial salvage (F
value  12, p  0.001).
TMP grade as a marker of the efficacy of reperfusion
therapy. We compared stenting with thrombolysis in their
ability to achieve a higher TMP grade. The proportion of
patients with TMP grade 2/3 was significantly higher after
stenting than after thrombolysis (70.9% vs. 48.1%, p 
0.001). Within the thrombolysis group, there was a higher
proportion of patients with TMP grade 2/3 among those
receiving the combination of alteplase plus abciximab than
among those receiving alteplase alone (56.3% vs. 38.7%, p
0.04). The results based on TMP grade, which showed the
superiority of stenting as a reperfusion option, were concor-
dant with the results emerging from the comparison of
stenting with thrombolysis in terms of myocardial salvage
and one-year mortality. Compared with thrombolysis,
stenting was associated with greater myocardial salvage
(0.54  0.29 vs. 0.30  0.55, p  0.001) and lower
mortality (2.2% vs. 9.0%, p  0.02). Within the thrombol-
ysis group, there were trends toward greater salvage (0.36 
0.50 vs. 0.23 0.60, p 0.2) and lower mortality (5.6% vs.
12.9%, p 0.14) among those receiving the combination of
alteplase plus abciximab than among those receiving alte-
plase alone.
DISCUSSION
This study shows, for the first time, that the TMP grade is
a reliable indicator of the degree of myocardial salvage
achieved with reperfusion therapy. It also enabled the
identification of the reperfusion therapy with superior effi-
cacy when stenting was compared with thrombolysis. Anal-
ysis of the TMP grade permitted even the detection of
subtle differences between the two thrombolytic regimens:
thrombolysis alone or combined with the glycoprotein
IIb/IIIa inhibitor abciximab. Our findings provide an ex-
Table 1. Baseline Characteristics
Characteristics
TMP Grade 2/3
(n  159)
TMP Grade 0/1
(n  108) p Value
Age (yrs) 59.8  13 62.1  12 0.13
Women 45 (28.3%) 23 (20.9%) 0.19
Current smoker 85 (52.8%) 44 (40.9%) 0.04
Diabetes mellitus 32 (20.2%) 19 (17.3%) 0.60
Hypercholesterolemia 108 (69.1%) 78 (71.8%) 0.59
Arterial hypertension 97 (61.4%) 72 (67.1%) 0.35
Previous myocardial infarction 16 (9.9%) 16 (15.2%) 0.24
Previous bypass surgery 5 (3.1%) 6 (5.6%) 0.50*
Multivessel disease 92 (58.0%) 69 (64.3%) 0.32
Killip class 2 7 (4.4%) 4 (3.7%) 0.96*
Anterior infarction 72 (45.2%) 56 (51.7%) 0.29
Peak CK (IU/ml) 973.4  1199 1,117.3  975 0.30
Symptom onset-to-treatment interval (min) 240.8  158 270.2  171 0.29
Initial perfusion defect (% of left ventricle) 31.1  19.5 33.9  19.4 0.27
*Fisher exact test. Data are presented as the mean value  SD or number (%) of patients.
CK  creatine kinase; TMP  TIMI myocardial perfusion.
Figure 1. Mean myocardial salvage index, mean final infarct size, and one-year mortality in patients with TIMI myocardial perfusion (TMP) grade 2/3
versus grade 0/1. LV  left ventricle.
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planation for the smaller infarct size (12) and better survival
(11,16) found in patients with AMI with higher TMP
grades after thrombolysis.
Several parameters have been proposed for the assessment
of reperfusion success in patients with AMI (17). Parame-
ters that reflect flow restoration not only in large epicardial
arteries but also in the microcirculation bed are being
investigated with increasing interest (18). New angiographic
indexes have been proposed for more reliable assessment of
reperfusion at the myocardial tissue level (9–11). Although
recent findings support the prognostic value of these indexes
(9–11), the exact underlying mechanisms are not clear.
Patients with TMP grade 2/3 after thrombolysis had a
smaller infarct size on scintigrams recorded 120 h after
treatment (12). However, the significance of a high TMP
grade in terms of myocardial salvage remains unknown. Our
study protocol provided us with paired scintigraphic studies
(baseline and follow-up) which are required for the calcu-
lation of myocardial salvage. It also allowed the comparison
of the two most commonly used reperfusion strategies—
thrombolysis and stenting—based on the TMP grading
system.
In contrast to other studies, which assessed the TMP
grade or blushing score on coronary angiograms obtained
shortly after reperfusion therapy (9,11,12,16), we used
coronary angiograms performed at one to two weeks after
primary treatment for the assessment of TMP grade. This
interval was chosen so that all patients would have final
angiographic and scintigraphic assessments of reperfusion
success very close to each other. This strategy minimizes the
chance for new events to occur between angiographic and
scintigraphic evaluations (e.g., vessel re-occlusion), with the
risk of introducing a bias in the relationship analysis. In
addition, assessing the TMP grade means assessing the
status of the coronary microvasculature, which, during
AMI, undergoes a series of changes leading to microvascular
dysfunction. Microvascular dysfunction is considered to
result from both ischemic injury and atheroembolism,
which develop in the first 1 to 2 h of AMI, and reperfusion
injury, which initiates after the restoration of blood flow in
the IRA and lasts up to 48 h after AMI onset (4). Neumann
et al. (19) have reported that both basal and peak flow
velocities increased at two weeks, compared with values
obtained immediately after percutaneous coronary revascu-
larization in patients with AMI. In the same line, Ito et al.
(20), who used myocardial contrast echocardiography to
assess the temporal changes in myocardial perfusion after
reflow, showed that contrast peak intensity in the late stage
of infarction might be a more useful estimate of myocardial
viability than contrast peak intensity at day 1. Therefore, the
TMP grade measured at one to two weeks after primary
treatment of AMI might more accurately reflect the “final”
status of microvascular function. Inherent to our strategy of
assessing the TMP grade at one to two weeks after the acute
event is the limitation that the validity of the results may be
restricted to those patients with AMI surviving this interval;
we are unable to provide data on patients who died before
the day of scheduled angiography. However, our specific
objective was to determine the potential relationship be-
tween the TMP grade by angiography and myocardial
salvage by scintigraphy, rather than the assessment of the
prognostic value of TMP grade, which has already been
demonstrated in previous studies (11). The number of
patients enrolled in the STOPAMI-1 and -2 trials was
relatively limited for analyses based on mortality.
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